THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM
Total 13F shares
86,674,105
Share change
-5,418,430
Total reported value
$383,021,167
Price per share
$4.42
Number of holders
85
Value change
-$34,265,495
Number of buys
52
Number of sells
42

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q2 2014

As of 30 Jun 2014, THERAPEUTICSMD INC - COM (TXMD) was held by 85 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 86,674,105 shares. The largest 10 holders included WELLINGTON MANAGEMENT CO LLP, FMR LLC, Bank of New York Mellon Corp, GILDER GAGNON HOWE & CO LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, RA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, BlackRock Fund Advisors, VANGUARD GROUP INC, and MILLENNIUM MANAGEMENT LLC. This page lists 85 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.